Navigation Links
NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
Date:7/14/2011

anism, releasing from bone marrow and traveling to the damaged region of the heart following an AMI. Treatment with AMR-001 involves infusion of an active population of these cells directly into a patient’s heart via an intra-coronary catheter six to eleven days after an AMI (i.e., after the “hot (inflammatory) phase”) and as such complements the body’s natural  rescue mechanism for those cells that face hypoxic stress (i.e., oxygen deprivation) as a result of an increased workload.

Unlike competitor cell therapy products being tested for cardiac repair post-AMI, NeoStem believes AMR-001 stands alone in its ability to claim all of the following attributes:

  • a confirmed mechanism of action
  • a cGMP (current good manufacturing practices) facility
  • an established dose that exceeds the threshold of biological activity
  • use of autologous cells that have no risk of rejection and are capable of integrating and providing local support, potentially for a prolonged period of time as demonstrated in pre-clinical animal experiments
  • cells that are not expanded, thereby eliminating the potential concerns associated with such expansion
  • composition of matter, methods and processes patents with long remaining life

  • To the Company's knowledge, this is the first stem cell trial in AMI ever conducted that prospectively established a significant relationship between dose and effect. NeoStem intends to enter the clinic for the start of the Phase II trial for AMR-001 no later than the  first quarter of 2012 and to commence a Phase I study in congestive heart failure in 2012.  The enrollment of this Phase II trial is estimated to complete within 12 months from start with data read-out 6 months after the last patient is treated.

    The definitive merger agreement provides for the issuance of an aggregate of 6,821,283 shares of NeoStem common stock and warrants to purchase an aggregate o
    '/>"/>

    SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
    2. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
    3. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
    4. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
    5. NeoStem Announces Warrant Exercise by Principal Shareholder
    6. NeoStem, Inc. Officially Launches Adult Stem Cell Collection Center and R&D Laboratory in Cambridge, Massachusetts
    7. NeoStem Pharmaceutical Subsidiary Announces Two cGMP Lines are Now Fully Operational in New Facility
    8. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
    9. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
    10. NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
    11. NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
    (Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
    (Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
    Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
    ... new Mayo,Clinic study found that regular physical exercise ... of the brain that affects nerve cells,involved in ... the,American Academy of Neurology Annual Meeting in Chicago ... impairment can function reasonably well,in everyday activities, but ...
    ... IND Filing for Novavax,s ... Seasonal Influenza Vaccine Candidate, ROCKVILLE, Md., April 16 ... has received positive results from an,immunogenicity study in ferrets inoculated ... enable Novavax to,complete its planned investigational new drug ("IND") application ...
    Cached Medicine Technology:Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 3
    (Date:3/27/2015)... TX (PRWEB) March 27, 2015 The ... is an essential source of information on and analysis ... US. The population of the US in 2013 amounted ... Growth Rate (CAGR) of 0.8% from 2008. The country’s ... of chronic diseases will help to boost the growth ...
    (Date:3/27/2015)... Naples, FL and London, UK (PRWEB) March 27, 2015 ... solution, announced today that it has appointed Sean Fitzgerald, ... the role of Chief Operating Officer and Interim Chief ... Vice President of leading education technology innovator, EverFi, backed ... Eric Schmidt, and Twitter founder Evan Williams. Prior to ...
    (Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health ... NOW! vitamin D demonstration project April 7 in the ... (MUSC), and will soon follow with a second phase ... to a minimum of 500 pregnant women at 17 ... service areas. The project will include patient and health ...
    (Date:3/27/2015)... 2015 When struck with the aftermath ... know where to begin. The latest eBook released ... attorney, offers accident victims a clear and concise process ... ensure their personal injury claim is seen through to ... first actions that should be taken immediately following the ...
    (Date:3/27/2015)... Trail mix is the perfect, healthy snack ... hikes and during the game! It’s portable, lightweight and provides ... to introduce a new line of specialty trail mixes that ... flavorful selections packed with nutritious, 100% all natural ingredients. , ... that add protein and fiber to your diet and boost ...
    Breaking Medicine News(10 mins):Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2
    ... Older adults who don,t get enough vitamin D ... at increased risk of developing mobility limitations and disability, according ... "This is one of the first studies to look at ... mobility limitations or disability in older adults," said lead author ...
    ... been approved since March 2011 in men with metastatic ... with hormone blockers and have already been pre-treated with ... pursuant to the "Act on the Reform of the ... Quality and Efficiency in Health Care (IQWiG) examined whether ...
    ... of Physicians (ACP), the second-largest physician group in the United ... aims to prevent one million heart attacks and strokes in ... Empowering Americans to make healthy choices such as preventing ... can reduce the number of people who need medical treatment ...
    ... Vitamin D deficiency is not healthy. However, new research from ... level of the essential vitamin is not good either. The ... results have just been published in the reputed scientific ... is instrumental in helping calcium reach our bones, thus lessening ...
    ... aspirin and other similar painkillers may help protect against ... a peer-reviewed journal of the American Cancer Society, the ... to the benefits of these commonly used medications. ... NSAIDs, which include aspirin, ibuprofen, and naproxen, as well ...
    ... Aggressive efforts to lower blood pressure in people with ... a new study The research shows that there ... with diabetes in the U.S. Department of Veterans Affairs, with ... controlled and 94 percent getting appropriate BP treatment. ...
    Cached Medicine News:Health News:Older adults may need more vitamin D to prevent mobility difficulties 2Health News:Cabazitaxel can offer an advantage in certain patients 2Health News:Cabazitaxel can offer an advantage in certain patients 3Health News:ACP joins Million Hearts to help save lives from preventable heart attacks and strokes 2Health News:Too much vitamin D can be as unhealthy as too little 2Health News:Commonly used painkillers may protect against skin cancer 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 3
    Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
    ... SEDIPLAST® is a completely closed system ... laboratory personnel from the risk associated ... uniquely designed erythrocyte sedimentation rate test ... convenience as well as reliable and ...
    ... Unlike other ESR products, SEDIPLAST® is ... design features to protect laboratory personnel ... handling. SEDIPLAST® is a uniquely designed ... provides greater safety and convenience as ...
    ... The use of guaiac as ... of blood is based on ... present in guaiac to quinones, ... a blue color. If blood ...
    Medicine Products: